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Contrast-Enhanced CMR Imaging
Reveals Myocardial Involvement
in Idiopathic Inﬂammatory
Myopathy Without Cardiac
Manifestations
Polymyositis (PM) and dermatomyositis (DM) are inflamma-
tory diseases affecting skeletal muscles and other internal
organs (1). Cardiac involvement occurs in up to 70% of
patients and may be lethal (1). The diagnosis, based on
electrocardiogram and laboratory and imaging investigations,
remains a challenge because of nonspecific clinical presenta-
tion and the lack of standardized criteria (1). Cardiac magnetic
resonance (CMR) is currently the best technique for diagnos-
ing cardiac fibrosis (2).
Our aim was to evaluate patients with PM/DM without
cardiac manifestations using CMR. Seven patients with PM (3
men/4 women) and 9 with DM (4 men/5 women) were
studied. They were consecutively selected if they did not
present any evidence of myocardial involvement, as shown by
clinical and laboratory evaluation, and if they had no comor-
bidities, such as known coronary artery or valvular disease,
obesity, diabetes, hypertension, hypercholesterolemia, alcohol-
ism, and cardiac infections.
Their median age was 44 years (range 32 to 79 years) and
the mean disease duration was 24 months (range 3 to 235
months), with 14 attaining remission of myopathy (6 PM, 8
DM, 8 to 12 months before the study), as shown by normal
inflammatory indexes (erythrocyte sedimentation rate,
C-reactive protein level), muscle enzyme assays, and improved
muscle strength tests. Disease-associated involvement other
than inflammatory myopathy was observed in all patients,
Figure 1. LGE Area in the Inferior Wall of the LV of a Patient With PM
Late gadolinium-enhanced (LGE) area in the inferior wall of the left ventr
dence of heart involvement. P  posterior.ncluding polyarthritis (5 PM, 1 DM), Raynaud phenomenon
3 PM, 2 DM), pulmonary fibrosis (2 DM), and sicca
ymptoms (1 PM, 1 DM); skin rashes appeared only in
atients with DM.
Left ventricular (LV) function and late gadolinium-
nhanced (LGE) areas were evaluated by 2 readers, and the
appa value was 0.86. Data, presented as medians and ranges,
ere compared by 2-sided Student t test and Fisher exact test.
alues of p  0.05 were considered to be statistically signif-
icant. In all patients, values were within normal range for LV
end-systolic volume (median 38 ml, range 23 to 64 ml), LV
end-diastolic volume (median 123 ml, range 86 to 184 ml),
and LV ejection fraction (median 70%, range 52% to 78%).
LGE was detected in 9 of 16 patients with PM/DM
(56.3%, including 6 of 7 patients with PM and 3 of 9 with
DM). There was a trend for more frequent LGE among
patients with PM, compared with those with DM (p 
0.060). LGE was epicardial or intramyocardial, sparing the
subendocardium (typical of past inflammation) and involved
approximately 5% of myocardial mass (median 4.4%, range 3%
to 7%). LGE involved the intraventricular septum in 8 patients
(5 with PM, 3 with DM), inferior wall in 3 (2 PM, 1 DM),
and lateral wall in 5 (3 PM, 2 DM). The anterior wall and apex
were affected in 1 and 2 patients with PM, respectively.
Lesions involving more than one area were identified in 4
patients with PM and 3 with DM. LGE images are presented
in Figures 1 and 2.
The frequency of heart involvement in PM/DM varies
between 6% and 75% (1,3). Although clinically overt disease is
rare, cardiac events are common causes of death (1). Cardiac
troponin I is the most reliable index of myocardial damage
(1,3). Reported experience about CMR in PM/DM is quite
limited (3).
In this study, we retrospectively assessed the possibility of
silent myocardial involvement in PM/DM using CMR. Our
results revealed LGE in patients with PM/DM without
(LV) in a patient with polymyositis (PM) (arrows), without clinical evi-icle
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Letter to the Editor 1325previous cardiac manifestation. The trend toward more frequent
occurrence of LGE in PM, compared with DM, is worth men-
tioning; however, a study with a larger number of patients is
necessary for definitive conclusions. As a preliminary report, our
study has several limitations. First, the imaging data were not
supported by biopsy (arduous in PM/DM because of patchy lesions
and the retrospective study design). Second, evaluation of T2 and
early T1 was missing. However, LGE bears prognostic value,
beyond other common predictors (4).
In conclusion, CMR unveiled silent myocardial involvement in
PM/DM. To establish the utility of CMR as a routine diagnostic
approach in PM/DM, further studies are mandatory, including
CMR in early and late PM/DM and correlation with clinical/
laboratory data.
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Figure 2. LGE Area in the IVS of the LV of a Patient With DM
LGE area in the intraventricular septum (IVS) of the LV in a patient with dermat
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